pimavanserin
pimavanserin is a pharmaceutical drug with 24 clinical trials. Currently 5 active trials ongoing. Historical success rate of 76.5%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
9
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
68.4%
13 of 19 finished
31.6%
6 ended early
5
trials recruiting
24
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pimavanserin for Insomnia in Veterans With PTSD
Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
Comparing Antipsychotic Medications in LBD Over Time
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Clinical Trials (24)
Pimavanserin for Insomnia in Veterans With PTSD
Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
Comparing Antipsychotic Medications in LBD Over Time
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Pimavanserin for Sleep in Parkinson Disease
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept
Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
Pimavanserin Treatment in TS
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 24